Evidence map›Paper›PMID 33297998›Full record

ArticleBMC cancer2020

Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.

Huan Lin, Gong Zhang, Xu-Chao Zhang, Xin-Lei Lian, Wen-Zhao Zhong, Jian Su, Shi-Liang Chen, Yi-Long Wu

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Risk of employment separation among workers with head and neck cancer: a longitudinal cohort study in Turin.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Huan LinGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China.
Gong ZhangMOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, 601, Huang-Pu Avenue West, Guangzhou, 510632, China.
Xu-Chao ZhangGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China.
Xin-Lei LianMOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, 601, Huang-Pu Avenue West, Guangzhou, 510632, China.
Wen-Zhao ZhongGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China.
Jian SuGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China.
Shi-Liang ChenGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China.
Yi-Long WuGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China. syylwu@live.cn.ORCID http://orcid.org/0000-0002-3611-0258
Guangdong Academy of Medical Sciences · CNJinan University · CNGuangzhou University of Chinese Medicine · CN

Funding

Guangdong Key Research and Development Program 2019B020226001National key research and development program 2017YFA0505000, 2018YFC0910200National Natural Science Foundation of China 81502439
6 · The paper itself

Abstract

backgroundThere were scarcely germline variants of familial lung cancer (LC) identified. We conducted an study with whole-exome sequencing of pedigrees with familial lung cancer to analyze the potential genetic susceptibility.

methodsProbands with the highest hereditary background were identified by our large-scale epidemiological study and five ones were enrolled as a learning set. The germline SNPs (single-nucleotide polymorphisms) of other five similar probands, four healthy individuals in the formerly pedigrees and three patients with sporadic LC were used as a validation set, controlled by three healthy individuals without family history of any cancer. The network of mutated genes was generated using STRING-DB and visualized using Cytoscape.

resultsSpecific and shared somatic mutations and germline SNPs were not the shared cause of familial lung cancer. However, individual germline SNPs showed distinct protein-protein interaction network patterns in probands versus healthy individuals and patients with sporadic lung cancer. SNP-containing genes were enriched in the PI3K/AKT pathway. These results were validated in the validation set. Furthermore, patients with familial lung cancer were distinguished by many germline variations in the PI3K/AKT pathway by a simple SVM classification method. It is worth emphasizing that one person with many germline variations in the PI3K/AKT pathway developed lung cancer during follow-up.

conclusionsThe phenomenon that the enrichments of germline SNPs in the PI3K/AKT pathway might be a major predictor of familial susceptibility to lung cancer.

Indexed as

Germ-Line MutationPolymorphism, Single NucleotideAdenocarcinomaCarcinoma, Small CellCarcinoma, Squamous CellCase-Control StudiesCell Transformation, NeoplasticExome SequencingFemaleGenetic Predisposition to DiseaseHumansIncidenceLung NeoplasmsMaleNeoplasm ProteinsNeoplastic Syndromes, HereditaryAKT1 protein, humanNeoplasm ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktFamilial lung cancerGermline variation networksPI3K/AKT pathwayWhole-exome sequencing

Identifiers

PMID33297998
PMCPMC7724858
OpenAlexW3109965590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.